This funding opportunity supports Centers that integrate clinical and translational research to advance understanding and management of atopic dermatitis. Emphasis is placed on chronic skin inflammation and the skin's defense mechanisms. The program encourages multidisciplinary approaches and clinical trial optional projects to improve patient outcomes.
Eligible applicants include a wide range of U.S.-based organizations such as nonprofits, state and local governments, educational institutions, tribal organizations, small businesses, and others. Foreign organizations and foreign components of U.S. organizations are not eligible.
